Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Maternal and Child Health Journal
|
January 4, 2022
Birth-Related Outcomes for Second Children Following Home Visiting Program Enrollment for New Parents of First Children
Margaret L Holland, Eileen M Condon, Gabrielle R Rinne, et al.
Clinical Lung Cancer
|
June 26, 2022
Characterization of ERBB2 (HER2) Alterations in Metastatic Non-small Cell Lung Cancer and Comparison of Outcomes of Different Trastuzumab-based Regimens
Sarah Waliany, Heather Wakelee, Kavitha Ramchandran, et al.
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society
|
June 10, 2023
MM-GLCM-CNN: A multi-scale and multi-level based GLCM-CNN for polyp classification
Shu Zhang, Jinru Wu, Enze Shi, et al.
Bone
|
January 3, 2015
μCT-based, in vivo dynamic bone histomorphometry allows 3D evaluation of the early responses of bone resorption and formation to PTH and alendronate combination therapy
Chantal M J de Bakker, Allison R Altman, Wei-Ju Tseng, et al.
Glycobiology
|
March 21, 2023
Toward an experimental system for the examination of protein mannosylation in Actinobacteria
Hirak Saxena, Nakita Buenbrazo, Won-Yong Song, et al.
Eclinicalmedicine
|
July 3, 2023
Efficacy and safety of topically applied therapeutic ammonia oxidising bacteria in adults with mild-to-moderate atopic dermatitis and moderate-to-severe pruritus: a randomised, double-blind, placebo-controlled, dose-ranging, phase 2b trial
Jonathan I Silverberg, Peter A Lio, Eric L Simpson, et al.
Cancer Research
|
October 8, 2009
Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases
Fawn Qian, Stefan Engst, Kyoko Yamaguchi, et al.
Cell Death and Differentiation
|
February 4, 2023
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells
Zilu Wang, Huimin Hu, Luuk Heitink, et al.
JCO Oncology Practice
|
November 17, 2022
Use of Machine Learning and Lay Care Coaches to Increase Advance Care Planning Conversations for Patients With Metastatic Cancer
Michael F Gensheimer, Divya Gupta, Manali I Patel, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Maternal and Child Health Journal
|
January 4, 2022
Birth-Related Outcomes for Second Children Following Home Visiting Program Enrollment for New Parents of First Children
Margaret L Holland, Eileen M Condon, Gabrielle R Rinne, et al.
Clinical Lung Cancer
|
June 26, 2022
Characterization of ERBB2 (HER2) Alterations in Metastatic Non-small Cell Lung Cancer and Comparison of Outcomes of Different Trastuzumab-based Regimens
Sarah Waliany, Heather Wakelee, Kavitha Ramchandran, et al.
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society
|
June 10, 2023
MM-GLCM-CNN: A multi-scale and multi-level based GLCM-CNN for polyp classification
Shu Zhang, Jinru Wu, Enze Shi, et al.
Bone
|
January 3, 2015
μCT-based, in vivo dynamic bone histomorphometry allows 3D evaluation of the early responses of bone resorption and formation to PTH and alendronate combination therapy
Chantal M J de Bakker, Allison R Altman, Wei-Ju Tseng, et al.
Glycobiology
|
March 21, 2023
Toward an experimental system for the examination of protein mannosylation in Actinobacteria
Hirak Saxena, Nakita Buenbrazo, Won-Yong Song, et al.
Eclinicalmedicine
|
July 3, 2023
Efficacy and safety of topically applied therapeutic ammonia oxidising bacteria in adults with mild-to-moderate atopic dermatitis and moderate-to-severe pruritus: a randomised, double-blind, placebo-controlled, dose-ranging, phase 2b trial
Jonathan I Silverberg, Peter A Lio, Eric L Simpson, et al.
Cancer Research
|
October 8, 2009
Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases
Fawn Qian, Stefan Engst, Kyoko Yamaguchi, et al.
Cell Death and Differentiation
|
February 4, 2023
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells
Zilu Wang, Huimin Hu, Luuk Heitink, et al.
JCO Oncology Practice
|
November 17, 2022
Use of Machine Learning and Lay Care Coaches to Increase Advance Care Planning Conversations for Patients With Metastatic Cancer
Michael F Gensheimer, Divya Gupta, Manali I Patel, et al.
Page
of 2